Indaptus Therapeutics
INDP
INDP
36 hedge funds and large institutions have $80.9M invested in Indaptus Therapeutics in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
Holders
36
Holding in Top 10
–
Calls
$508K
Puts
$285K
Top Buyers
| 1 | +$903K | |
| 2 | +$263K | |
| 3 | +$248K | |
| 4 |
PC
PA Capital
Richmond,
Virginia
|
+$225K |
| 5 |
Morgan Stanley
New York
|
+$200K |
Top Sellers
| 1 | -$4.45M | |
| 2 | -$2.18M | |
| 3 | -$987K | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$609K |
| 5 |
CC
Caxton Corporation
Princeton,
New Jersey
|
-$318K |